Education Qualifications: MBBS, M Med (Internal Medicine), FAMS (Internal Medicine), FAMS (Rheumatology), FRCP (Edinburgh)
Professor Fong Kok Yong was appointed Deputy Group Chief Executive Officer (Medical and Clinical Services), SingHealth from 1 July 2017. He is a Senior Consultant in Department of Rheumatology and Immunology at SGH.
Professor Fong is also the Chairman of the Residency Advisory Committee for Rheumatology (Ministry of Health) and Member of the Residency Advisory Committee for Internal Medicine (Ministry of Health) since 2012. He is also the Associate Editor for APLAR Journal of Rheumatology since 2006 and for Singapore Medical Journal since 2008.
He is a Fellow of Academy Medicine, Singapore in Internal Medicine and Rheumatology and Royal College of Edinburgh, UK.
In recognition of his immense contributions and remarkable leadership, Professor Fong is the deserving recipient of many awards, among them the National Outstanding Clinician Award and the Seah Cheng Siang Professorship in Medicine. He was pivotal in the development of Rheumatology in Singapore, and established the SGH Autoimmunity and Rheumatology Centre in May 2013, which brought together quality patient care, education and research. He is a respected mentor to many clinicians and leaders, and has had more than 100 papers published in peer-reviewed journals.
- Chairman, Medical Board, Singapore General Hospital (Nov 2012-Oct 2019)
- Senior Associate Dean, Office of Academic and Clinical Development, Duke-NUS Medical School (Nov 2012-Oct 2019)
- Member, Singapore Society of Immunology, Allergy and Rheumatology (1994-Present)
- Member, Academy of Medicine, Singapore (1996-Present)
- Member, Singapore Medical Association (1980-Present)
- Long Service Award for contribution to HSA (2017)
- Appreciation Award for 10 years contribution to Medicine Advisory Committee, MOH (2014)
- Appreciation Award, Excellent Stakeholder and Partnership Awards, HSA (2013)
- National Medical Excellence Award (National Outstanding Clinician) (2013)
- National Day Award (Long Service) (2012)
Selected Publications:
The risk of tuberculosis in SLE patients from an Asian tertiary hospital. Yang Y, Thumboo J, Tan BH, Tan TT, Fong CHJ, Ng HS, Fong KY. Rheumatol Int. 2017 Jun;37(6):1027-1033. doi: 10.1007/s00296-017-3696-3. Epub 2017 Mar 12.
Prognostic factors for mortality due to pneumonia among adults from different age groups in Singapore and mortality predictions based on PSI and CURB-65. Zhang ZX1,2, Yong Y, Tan WC, Shen L, Ng HS, Fong KY. Singapore Med J. 2017 Aug 14. doi: 10.11622/smedj.2017079.
Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases. Flint SM, Jovanovic V, Teo BW, Mak A, Thumboo J, McKinney EF, Lee JC, MacAry P, Kemeny DM, Jayne DR, Fong KY, Lyons PA, Smith KG. RMD Open. 2016 May 16;2(1):e000183.
Use of magnetic resonance imaging in detecting subclinical synovitis in rheumatoid arthritis and correlation of imaging findings with interleukin-18 levels. Chew LC, Chandra Mohan P, Chan LP, Fong KY, Thumboo. Int J Rheum Dis. 2016 Aug;19(8):790-8.
Assessment of arterial elastance and ventricular-arterial coupling in patients with systemic lupus erythematosus. Chin CW, Le TT, Gao F, Ng MX, Chin CY, Huang FQ, Fong KY, Thumboo J, Tan RS. Int J Cardiol. 2014 Sep 20;176(2):504-5.
Endothelial function is associated with myocardial diastolic function in women with systemic lupus erythematosus. Calvin W.L. Chin, Chee-Yang Chin, Marie X. R. Ng, Thu-Thao Le, Fei-Qiong Huang, Fong KY, Julian Thumboo, Re-San Tan. Rheumatology International. 2014 Sep;34(9):1281-5
The effect of comorbidity on hospital mortality in patients with SLE from an Asian tertiary hospital. Y Yang, J Thumboo, A Earnest, SL Yong, Fong KY. Lupus. June 2014 23: 714-720
Disease patterns of rheumatology outpatients seen in a tertiary hospital serving a multi-ethnic, urban Asian population in Singapore. Ng X, Low AH, Chew LC, Chong YY, Fong KY, Lui NL, Sim E, Tan YK, Yoong J, Thumboo J. Int J Rheuma Dis. 2013 Jun; 16(3): 273-8.
Height and mental health and health utility among ethnic Chinese in a polyclinic sample in Singapore. Cheung YB, Wee HL, Luo N, Tan CB, Fong KY, Thumboo J. Ann Acad Med Singapore. 2013 Feb; 42(2):73-9
Evaluation of a new multi-parallel line immunoassay for systemic sclerosis-associated antibodies in an Asian population. Low AH, Wong S, Thumboo J, Ng SC, Lim JY, Ng X, Earnest A, Fong KY. Rheumatology (Oxford). 2012 Aug; 51(8):1465-70.
An exploratory study of response shift in health-related quality of life and utility assessment among patients with osteoarthritis undergoing total knee replacement surgery in a tertiary hospital in Singapore. Zhang XH, Li SC, Xie F, Lo NN, Yang KY, Yeo SJ, Fong KY, Thumboo J.Value Health. 2012 Jan-Feb;15 (1Suppl) : S72-8.
HLA-DQ A1, -DQB1 and -DRB1 gene polymorphism--in Malay type 1 diabetes mellitus patients and their use for risk prediction. Rohana AG, Loh KC, Tin SK, Soh CH, Nazaimoon WM, Fong KY, Azmi KN, Khalid BA. Med J Malaysia. 2011 Jun;66(2):133-7.
Health-related quality of life of patients with systemic lupus erythematosus in asia : How can this be improved ? Thumboo J, Fong KY. Lupus. 2010;19(12):1430-5.
Neuropsychiatric lupus – clinical challenges, brain-reactive autoantibodies and treatment strategies. Fong KY, Thumboo J. Lupus. 2010;19(12):1399-403
A case of refractory vasculitic ulcers in a systemic lupus erythematosus patient responding to rituximab and hyperbaric oxygen therapy.Lui NL, Thumboo J, Fong KY. Int J Rheum Dis. 2009 Dec;12(4):366-9
H-Index: 35 (Google Scholar Citation) (as at 28 Feb 2019)